Is Innate Pharma S.A. (IPHA) a Buy, Sell, or Hold?
NASDAQ : IPHA
Innate Pharma S.A.
$1.75 USD
-$0.03 (-1.41%)
- Volume
- 10.42K
- Average Volume
- 68.57K
- Market Capitalization
- $164.33M
- P/E Ratio
- -2.74
- Dividend Yield
- 0.00%
- Price Target
- $3.50
- Year High
- $2.63
- Year Low
- $1.17
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.27
IPHA vs. The Competition
| Properties | IPHA | APLT | CGEN | CRBP |
|---|---|---|---|---|
| Market Cap | $164.33M | $14.86M | $224.09M | $112.94M |
| Shares Outstanding | $93.9M | $144.3M | $94.55M | $12.54M |
| P/E Ratio | -2.74 | -0.24 | 6.46 | -1.37 |
| EPS | -0.54 | -0.43 | 0.37 | -6.35 |
| Day Low | 1.72 | 0.103 | 2.27 | 8.5 |
| Day High | 1.75 | 0.103 | 2.38 | 9.151 |
| Year Low | 1.17 | 0.09 | 1.3 | 7.12 |
| Year High | 2.63 | 1.5 | 3.24 | 20.56 |
| Average Price 50 | 1.78476 | 0.14612 | 2.3872 | 9.0761 |
| Average Price 200 | 1.74663 | 0.46257 | 2.0481 | 10.0677 |
| Volume | 10425 | - | 153.81K | 210.03K |
| Average Volume | - | - | - | - |